Corporate Practice of Medicine: A State-by-State Review Framework

What does corporate practice of medicine mean for a brand owner?

The commercial business can have a name, audience, customer-acquisition strategy and technology experience. Medical evaluation and treatment remain professional services. The important boundary is not simply whether a founder calls the business a brand, clinic or platform; it is what each entity does and who has authority over the care.

A useful first document identifies the parties and their responsibilities. Show the brand, technology or management organization, professional medical entity, individual clinicians, pharmacy and any laboratory. Explain which agreement connects each pair. Then describe the patient journey in the same terms. If the diagram and the actual workflow disagree, resolve the mismatch before expanding into new states.

The white-label telehealth model can coordinate the experience under a consumer brand without assigning medical decisions to the brand owner. TEHR provides technology and administrative infrastructure; independent licensed providers make clinical decisions. That distinction should appear in the workflow, commercial expectations and public disclosures, not only in an isolated disclaimer.

Why is a simple fifty-state yes-or-no chart misleading?

A state's treatment of professional entities is not the only relevant question. The answer may depend on the profession, the legal form, ownership percentages, permitted exceptions, contractual control and the services being delivered. Other requirements can affect prescribing, fees, privacy, supervision and pharmacy relationships even when a particular corporate structure is permitted.

For that reason, a responsible expansion map has more than a green or red cell. It needs a source, an effective date, the business facts reviewed and the limits of the conclusion. A state approved for one service or clinician type should not silently become approved for every new category.

Keep a review record for each jurisdiction and program combination. Record the actual question answered, the primary authority, the reviewer, the operational conditions and the next trigger for review. If an answer is unresolved, retain that state as unresolved for that program rather than borrowing a conclusion from a neighboring state. This is an operating discipline, not a claim that every state imposes the same restrictions.

What does California demonstrate about control?

The Medical Board of California's practice information explains that unlicensed entities cannot direct medical decisions. Its examples extend beyond treatment selection to specified control matters involving records, staffing and related practice decisions. The board also warns that simply employing a medical director does not solve prohibited ownership or control.

The lesson for an operator is to examine the powers written into the contract and the powers exercised in the product. A dashboard permission that allows commercial staff to override a provider decision can undermine a carefully worded agreement. A bonus or escalation process designed around prescription approval can create similar tension even when nobody explicitly asks for a particular clinical result.

Do not turn the California example into a nationwide conclusion. Use it to ask better questions: who approves clinical policies, who may change them, who handles a disagreement, and which decisions are reserved? Review the actual arrangement with counsel familiar with the relevant state and professional services.

What does Oregon demonstrate about exceptions and changing law?

Oregon's ORS 676.555 contains detailed management-services restrictions, exceptions and applicability provisions. It distinguishes administrative services from medical practice and addresses control that affects clinical decision-making. The text includes specific telemedicine-related exceptions, rather than a blanket rule that remote businesses are outside the framework.

That level of detail matters. Reading a headline about a new restriction can miss an exception; reading a headline about an exception can miss the provisions that still apply. Existing arrangements and new arrangements may also have different implementation dates. The legislature's chapter page flags subsequent amendments, so the edition and amendment history need attention.

Use the Oregon example as a reminder to record the date and facts behind a legal conclusion. Do not copy a structure diagram from an older transaction and assume it remains suitable. A new brand, changed ownership, new medical entity or altered control provision can require a fresh analysis. The result should be translated into concrete operating instructions that the product and support teams can follow.

What should a state review actually contain?

Ask for conclusions that identify conditions, not just a statement that the business is compliant. For example, a review might depend on a particular professional entity retaining a decision. The implementation team needs to know where that decision occurs, who has access and what evidence is retained.

The table should also have a change owner. When a new medication, profession, geography or partner is introduced, someone must decide whether the existing review still applies. A static document without a change process quickly loses value.

How do licensure and prescribing fit into the review?

Ownership structure and individual authority are separate layers. HHS explains that cross-state care depends on state licensure pathways and recommends verifying patient location before appointments. A network with nationwide reach does not mean each clinician can treat every patient or that every program is available everywhere.

Build the routing logic around the actual service, patient location and clinician authority. Include a way to stop or redirect a journey when those facts do not match. When a patient travels, the relevant location may differ from the address originally entered at signup. A commercial promise of convenience should not make that verification disappear.

Controlled substances add another layer. Read the Ryan Haight and asynchronous prescribing guide before assuming a questionnaire can support a particular treatment. Keep clinical protocol decisions with the independent provider organization, and make the platform reflect those decisions accurately.

How can the business support care without controlling it?

Start with clear service definitions. Scheduling, account support, payment administration, technical troubleshooting and marketing operations can be described separately from evaluation, diagnosis, treatment and prescribing. The precise permissible arrangement still depends on the state and contracts, but clarity helps prevent commercial staff from drifting into clinical responsibilities.

Write escalation instructions in ordinary language. A support representative should know when a question concerns an invoice and when it requires a clinician or pharmacy. Give the team a destination and response expectation for each type of question. Avoid asking nonclinical staff to interpret symptoms or decide whether a prescription should continue.

Audit incentives as well as permissions. A rejected prescription should not automatically be classified as a provider failure. A delayed shipment should not be solved by changing the clinical order without authorization. Measure service reliability using the process the organization can legitimately improve, such as clear communication, completed handoffs and timely routing.

The TEHR platform discussion should include these role boundaries. A useful demonstration follows an exception case all the way through, showing who can see, change and approve each step.

What changes when an existing office becomes a nationwide brand?

An existing local business brings relationships and operating experience, but its current arrangements are not automatically portable. A patient base, office license or local pharmacy relationship does not by itself establish the remote model in a new jurisdiction. Separate the local service from the proposed remote expansion and identify which parts remain the same.

Review records and continuity early. Who holds the historical chart, which entity will deliver future care, how will patients understand the change, and which records can be transferred for which purpose? Use the migration checklist to connect those decisions with the technical work.

Then build the commercial plan around the approved scope. TEHR pricing uses a flat platform subscription and flat transaction fee with 0% revenue share, but the proposal must still describe the services and third-party arrangements involved. A pricing structure is not a substitute for analyzing the legal relationship.

A sound expansion plan can be ambitious without declaring every future state and program ready on day one. Launch the defined service, preserve independent care and expand as the evidence supports it.

What else should you know?